Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-03 · accession 0001968202-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-04-05 | 2023-04-03 | REGN | RYAN ARTHUR F | Dir | S - Sale | $819.31 | -100 | 19.1K | -0.5% | -$81.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-03 | S | D | 9 | $822.37 | 19,053 | D | — | — | (F7) Represents volume-weighted average price of sales of 9 shares of Company stock on April 3, 2023 at prices ranging from $822.06 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price. |
| 2 | Common | Common Stock | 2023-04-03 | S | D | 6 | $823.34 | 19,047 | D | — | — | (F8) Represents volume-weighted average price of sales of 6 shares of Company stock on April 3, 2023 at prices ranging from $823.11 to $823.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price. |
| 3 | Common | Common Stock | 2023-04-03 | S | D | 1 | $821.61 | 19,062 | D | — | — | |
| 4 | Common | Common Stock | 2023-04-03 | S | D | 5 | $820.55 | 19,063 | D | — | — | (F6) Represents volume-weighted average price of sales of 5 shares of Company stock on April 3, 2023 at prices ranging from $820.22 to $820.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price. |
| 5 | Common | Common Stock | 2023-04-03 | S | D | 32 | $819.48 | 19,068 | D | — | — | (F5) Represents volume-weighted average price of sales of 32 shares of Company stock on April 3, 2023 at prices ranging from $819.01 to $819.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price. |
| 6 | Common | Common Stock | 2023-04-03 | S | D | 27 | $818.47 | 19,100 | D | — | — | (F4) Represents volume-weighted average price of sales of 27 shares of Company stock on April 3, 2023 at prices ranging from $818.04 to $818.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price. |
| 7 | Common | Common Stock | 2023-04-03 | S | D | 13 | $817.49 | 19,127 | D | — | — | (F3) Represents volume-weighted average price of sales of 13 shares of Company stock on April 3, 2023 at prices ranging from $817.01 to $817.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price. |
| 8 | Common | Common Stock | 2023-04-03 | S | D | 7 | $816.58 | 19,140 | D | — | — | (F2) Represents volume-weighted average price of sales of 7 shares of Company stock on April 3, 2023 at prices ranging from $816.15 to $816.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price. |